Description

This presentation explores advancements in diagnosing and treating discogenic low back pain, focusing on the interplay of cellular processes and emerging therapies. It covers PRP, bone marrow aspirate, and allogeneic MSCs, demonstrating their potential for long-term pain relief. Additionally, the speaker discusses exosomes as biomarkers for tracking degeneration and new regenerative approaches. Future interventions, including peptides and nucleus replacement devices, offer promising alternatives. The presentation emphasizes the importance of personalized treatment approaches based on cellular composition and highlights ongoing clinical trials aiming to transform discogenic pain management.